Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PT Royal Prima Tbk's enterprise value is Rp333,806 Mil.
PT Royal Prima Tbk's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was Rp-19,242 Mil. Therefore, PT Royal Prima Tbk's EV-to-EBITDA for today is -17.35.
The historical rank and industry rank for PT Royal Prima Tbk's EV-to-EBITDA or its related term are showing as below:
ISX:PRIM'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -460.74 Med: 13.23 Max: 426.47
Current: -17.35
During the past 12 years, the highest EV-to-EBITDA of PT Royal Prima Tbk was 426.47. The lowest was -460.74. And the median was 13.23.
ISX:PRIM's EV-to-EBITDA is ranked worse than 100% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 10.97
vs ISX:PRIM: -17.35
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
PT Royal Prima Tbk (ISX:PRIM) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Royal Prima Tbk's PE Ratio (TTM) for today is calculated as:
PT Royal Prima Tbk's share price for today is Rp104.00.
PT Royal Prima Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-5.760.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for PT Royal Prima Tbk's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:PRIM vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, PT Royal Prima Tbk's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Royal Prima Tbk EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Royal Prima Tbk's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PT Royal Prima Tbk's EV-to-EBITDA falls into.
PT Royal Prima Tbk's current Enterprise Value is Rp333,806 Mil.
PT Royal Prima Tbk's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-19,242 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Royal Prima Tbk (ISX:PRIM) has a EV-to-EBITDA of -17.35 as of Jul. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PT Royal Prima Tbk. According to the industry distribution chart, PT Royal Prima Tbk ranks #999999 out of 509 companies in the Healthcare Providers & Services industry.
Is PT Royal Prima Tbk's EV-to-EBITDA too high?
PT Royal Prima Tbk's current EV-to-EBITDA is -17.35. Based on the distribution chart, PT Royal Prima Tbk ranks #999999 out of 509 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Royal Prima Tbk has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Royal Prima Tbk's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Royal Prima Tbk ranks #999999 out of 509 companies for EV-to-EBITDA. This places PT Royal Prima Tbk in the lower half of its industry. The industry median EV-to-EBITDA is 10.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.97, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PT Royal Prima Tbk. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Royal Prima Tbk's current EV-to-EBITDA is -17.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Royal Prima Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Royal Prima Tbk (ISX:PRIM) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp81.83, compared to a current price of Rp104.00 — trading 27.1% above its estimated fair value. The current EV-to-EBITDA is -17.35. PT Royal Prima Tbk's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For PT Royal Prima Tbk (ISX:PRIM), the current EV-to-EBITDA is -17.35 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Royal Prima Tbk (ISX:PRIM) Overvalued in 2026?
Based on GuruFocus' analysis, PT Royal Prima Tbk stock appears to be overvalued.
The current stock price of Rp104.00 is trading 27.1% above its estimated GF Value™ of Rp81.83.
GuruFocus considers PT Royal Prima Tbk to be Modestly Overvalued.
Key valuation signals for ISX:PRIM:
EV-to-EBITDA: -17.35
GF Value™: Rp81.83 vs. price of Rp104.00 (27.1% above fair value)
No single metric tells the full story. See the ISX:PRIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Royal Prima Tbk is engaged in health services which consist of the provision of hospital services, polyclinics, hall treatment, maternity hospital, and specialist hospital. It has three geographic segments: RSU Royal Prima, RS Royal Prima Jambi, and Rumah Sakit Marelan. The company generates the majority of its revenue from RSU Royal Prima segment. The company generates revenue from Drugs and medical supplies, doctors' and nurses' fees, Hospital facilities, Room services, and Others.
73GF Score
Get the complete analysis for ISX:PRIM
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRIM has been successfully added to your 
